Guidelines for Pharmacoeconomic Studies Michael F. Drummond Guest Editorial 15 November 2012 Pages: 493 - 497
Effects of Capitation on Health of the Chronically III Sylvia K. ReedKumar Maharaj Leading Article 15 November 2012 Pages: 506 - 512
The Costs of Rheumatoid Arthritis Saralyn H. AllaireMark J. PrashkerRobert F. Meenan Review Article 15 November 2012 Pages: 513 - 522
Quality-of-Life Instruments in Hypertension Christopher J. BulpittAstrid E. Fletcher Review Article 15 November 2012 Pages: 523 - 535
Costs of Illness in Cost-Effectiveness Analysis Thomas A. Hodgson Review Article 15 November 2012 Pages: 536 - 552
Cost Effectiveness of Antiviral Treatment with Zalcitabine plus Zidovudine for AIDS Patients with CD4+ Counts Less Than 300/ยต1 in 5 European Countries Kit SimpsonEvi J. HatzialldreuAnna N.A. Tosteson Pharmacoeconomic Drug Evaluation 15 November 2012 Pages: 553 - 562
Colfosceril Palmitate Harriet M. BrysonRuth Whittington Pharmacoeconomic Drug Evaluation 15 November 2012 Pages: 563 - 577
Measuring Quality of Life in Inflammatory Bowel Disease Douglas A. Drossman Current Comment 15 November 2012 Pages: 578 - 580
How Much Faith Can We Have in Pharmacoeconomic Analyses? Hind T.Sheldon Xiaodong Letter to the Editor 15 November 2012 Pages: 584 - 586